Global Infectious Disease Therapeutics Market By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, and Others), By Treatment Type (Antibiotics, Antiviral Drugs, Antifungal Drugs, Antiparasitic Drugs, and Others), By End-use (Hospitals, Clinics, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
• 2.1. Global Market Insights and Industry Overview
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunities
  • 2.2.4. Key Infectious Disease Therapeutics Market Trends
• 2.3. Regulatory Framework
• 2.4. Opportunity Map Analysis
• 2.5. Opportunity Orbits
• 2.6. PESTLE Analysis
• 2.7. PORTER’S Five Force Analysis
• 2.8. Drivers & Restraints Impact Analysis
• 2.9. Value Chain Analysis
  • 2.9.1. List of Raw Materials Suppliers
  • 2.9.2. List of XYZ Manufacturers
  • 2.9.3. List of Dealer/Distributors
• 2.10. Regional Market Share and BPS Analysis
• 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Infectious Disease Therapeutics Market Analysis and Forecast, By Segment, 2019-2033
• 3.1. Key Findings
• 3.2. Global Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 3.3. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  • 3.3.1. HIV
    • 3.3.1.1. Insights
    • 3.3.1.2. Key Takeaways
  • 3.3.2. Hepatitis
    • 3.3.2.1. Insights
    • 3.3.2.2. Key Takeaways
  • 3.3.3. Influenza
    • 3.3.3.1. Insights
    • 3.3.3.2. Key Takeaways
  • 3.3.4. TB
    • 3.3.4.1. Insights
    • 3.3.4.2. Key Takeaways
  • 3.3.5. Malaria
    • 3.3.5.1. Insights
    • 3.3.5.2. Key Takeaways
  • 3.3.6. Others
    • 3.3.6.1. Insights
    • 3.3.6.2. Key Takeaways
• 3.4. Global Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 3.5. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  • 3.5.1. Antibiotics
    • 3.5.1.1. Insights
    • 3.5.1.2. Key Takeaways
  • 3.5.2. Antiviral Drugs
    • 3.5.2.1. Insights
    • 3.5.2.2. Key Takeaways
  • 3.5.3. Antifungal Drugs
    • 3.5.3.1. Insights
    • 3.5.3.2. Key Takeaways
  • 3.5.4. Antiparasitic Drugs
    • 3.5.4.1. Insights
    • 3.5.4.2. Key Takeaways
  • 3.5.5. Others
    • 3.5.5.1. Insights
    • 3.5.5.2. Key Takeaways
• 3.6. Global Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 3.7. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
  • 3.7.1. Hospitals
    • 3.7.1.1. Insights
    • 3.7.1.2. Key Takeaways
  • 3.7.2. Clinics
    • 3.7.2.1. Insights
    • 3.7.2.2. Key Takeaways
  • 3.7.3. Others
    • 3.7.3.1. Insights
    • 3.7.3.2. Key Takeaways
• 4. Global Infectious Disease Therapeutics Market Analysis and Forecast, By Region, 2019-2033
• 4.1. Key Findings
• 4.2. Global Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
  • 4.2.1. North America
    • 4.2.1.1. Regional Insights
  • 4.2.2. Europe
    • 4.2.2.1. Regional Insights
  • 4.2.3. Asia Pacific
    • 4.2.3.1. Regional Insights
  • 4.2.4. Latin America
    • 4.2.4.1. Regional Insights
  • 4.2.5. Middle East & Africa
    • 4.2.5.1. Regional Insights
• 4.3. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Region
• 5. North America Infectious Disease Therapeutics Market Analysis and Forecast, 2019-2033
• 5.1. Key Findings
• 5.2. North America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 5.3. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• 5.4. North America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 5.5. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• 5.6. North America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 5.7. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• 5.8. North America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
• 5.9. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
  • 5.9.1. The US
  • 5.9.2. Canada
• 6. Europe Infectious Disease Therapeutics Market Analysis and Forecast, 2019-2033
• 6.1. Key Findings
• 6.2. Europe Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 6.3. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• 6.4. Europe Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 6.5. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• 6.6. Europe Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 6.7. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• 6.8. Europe Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
• 6.9. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
  • 6.9.1. Germany
  • 6.9.2. The UK
  • 6.9.3. France
  • 6.9.4. Spain
  • 6.9.5. Italy
  • 6.9.6. Russia
  • 6.9.7. Netherland
  • 6.9.8. Rest of Europe
• 7. Asia Pacific Infectious Disease Therapeutics Market Analysis and Forecast, 2019-2033
• 7.1. Key Findings
• 7.2. Asia Pacific Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 7.3. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• 7.4. Asia Pacific Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 7.5. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• 7.6. Asia Pacific Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 7.7. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• 7.8. Asia Pacific Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
• 7.9. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
  • 7.9.1. China
  • 7.9.2. Japan
  • 7.9.3. South Korea
  • 7.9.4. India
  • 7.9.5. Australia
  • 7.9.6. New Zealand
  • 7.9.7. Singapore
  • 7.9.8. Thailand
  • 7.9.9. Vietnam
  • 7.9.10. Rest of Asia Pacific
• 8. Latin America Infectious Disease Therapeutics Market Analysis and Forecast, 2019-2033
• 8.1. Key Findings
• 8.2. Latin America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 8.3. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• 8.4. Latin America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 8.5. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• 8.6. Latin America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 8.7. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• 8.8. Latin America Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
• 8.9. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
  • 8.9.1. Brazil
  • 8.9.2. Mexico
  • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Infectious Disease Therapeutics Market Analysis and Forecast, 2019-2033
• 9.1. Key Findings
• 9.2. Middle East & Africa Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2019-2033
• 9.3. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• 9.4. Middle East & Africa Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2019-2033
• 9.5. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• 9.6. Middle East & Africa Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
• 9.7. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• 9.8. Middle East & Africa Infectious Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
• 9.9. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
  • 9.9.1. South Africa
  • 9.9.2. Saudi Arabia
  • 9.9.3. UAE
  • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
• 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
• 10.2. Overview of Major Market Players
• 10.3. Competitor Landscape
• 10.4. Strategic Mapping
• 10.5. Company Life Cycle Analysis
• 10.6. Company Market Share Analysis
• 10.7. Company Profiles
  • 10.7.1. Novartis AG
    • 10.7.1.1. Company Details
    • 10.7.1.2. Business Overview
    • 10.7.1.3. Product Portfolio
    • 10.7.1.4. Financial Insights
    • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.1.6. SWOT Analysis
    • 10.7.1.7. Geographic Footprint
  • 10.7.2. Gilead Sciences, Inc.
    • 10.7.2.1. Company Details
    • 10.7.2.2. Business Overview
    • 10.7.2.3. Product Portfolio
    • 10.7.2.4. Financial Insights
    • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.2.6. SWOT Analysis
    • 10.7.2.7. Geographic Footprint
  • 10.7.3. GSK plc.
    • 10.7.3.1. Company Details
    • 10.7.3.2. Business Overview
    • 10.7.3.3. Product Portfolio
    • 10.7.3.4. Financial Insights
    • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.3.6. SWOT Analysis
    • 10.7.3.7. Geographic Footprint
  • 10.7.4. Janssen Pharmaceutica NV
    • 10.7.4.1. Company Details
    • 10.7.4.2. Business Overview
    • 10.7.4.3. Product Portfolio
    • 10.7.4.4. Financial Insights
    • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.4.6. SWOT Analysis
    • 10.7.4.7. Geographic Footprint
  • 10.7.5. F. Hoffmann-La Roche Ltd.
    • 10.7.5.1. Company Details
    • 10.7.5.2. Business Overview
    • 10.7.5.3. Product Portfolio
    • 10.7.5.4. Financial Insights
    • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.5.6. SWOT Analysis
    • 10.7.5.7. Geographic Footprint
  • 10.7.6. BioCryst Pharmaceuticals, Inc.
    • 10.7.6.1. Company Details
    • 10.7.6.2. Business Overview
    • 10.7.6.3. Product Portfolio
    • 10.7.6.4. Financial Insights
    • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.6.6. SWOT Analysis
    • 10.7.6.7. Geographic Footprint
  • 10.7.7. Boehringer Ingelheim Pharmaceuticals, Inc.
    • 10.7.7.1. Company Details
    • 10.7.7.2. Business Overview
    • 10.7.7.3. Product Portfolio
    • 10.7.7.4. Financial Insights
    • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.7.6. SWOT Analysis
    • 10.7.7.7. Geographic Footprint
  • 10.7.8. Merck & Co., Inc.
    • 10.7.8.1. Company Details
    • 10.7.8.2. Business Overview
    • 10.7.8.3. Product Portfolio
    • 10.7.8.4. Financial Insights
    • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.8.6. SWOT Analysis
    • 10.7.8.7. Geographic Footprint
  • 10.7.9. AbbVie Inc.
    • 10.7.9.1. Company Details
    • 10.7.9.2. Business Overview
    • 10.7.9.3. Product Portfolio
    • 10.7.9.4. Financial Insights
    • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.9.6. SWOT Analysis
    • 10.7.9.7. Geographic Footprint
  • 10.7.10. Pfizer Inc.
    • 10.7.10.1. Company Details
    • 10.7.10.2. Business Overview
    • 10.7.10.3. Product Portfolio
    • 10.7.10.4. Financial Insights
    • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.10.6. SWOT Analysis
    • 10.7.10.7. Geographic Footprint
  • 10.7.11. Moderna, Inc.
    • 10.7.11.1. Company Details
    • 10.7.11.2. Business Overview
    • 10.7.11.3. Product Portfolio
    • 10.7.11.4. Financial Insights
    • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    • 10.7.11.6. SWOT Analysis
    • 10.7.11.7. Geographic Footprint
• 11. Methodology and Data Source
• 11.1. Methodology/Research Approach
• 11.2. Market Size Estimation
• 11.3. Market Breakdown and Data Triangulation
• 11.4. Data Source
• 11.5. Secondary Sources
• 11.6. Primary Sources
• 11.7. Appendix
• 11.8. Disclaimer

List of Tables

• Table 1. Global Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 2. Global Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 3. Global Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 4. Global Infectious Disease Therapeutics Market Value (US$ Mn), By Region, 2019-2033
• Table 5. North America Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 6. North America Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 7. North America Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 8. North America Infectious Disease Therapeutics Market Value (US$ Mn), By Country, 2019-2033
• Table 9. The US Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 10. The US Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 11. The US Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 12. Canada Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 13. Canada Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 14. Canada Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 15. Europe Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 16. Europe Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 17. Europe Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 18. Europe Infectious Disease Therapeutics Market Value (US$ Mn), By Country, 2019-2033
• Table 19. Germany Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 20. Germany Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 21. Germany Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 22. The UK Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 23. The UK Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 24. The UK Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 25. The UK Infectious Disease Therapeutics Market Value (US$ Mn), By Application, 2019-2033
• Table 26. France Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 27. France Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 28. France Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 29. Spain Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 30. Spain Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 31. Spain Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 32. Italy Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 33. Italy Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 34. Italy Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 35. Italy Infectious Disease Therapeutics Market Value (US$ Mn), By Application, 2019-2033
• Table 36. Russia Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 37. Russia Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 38. Russia Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 39. Netherland Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 40. Netherland Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 41. Netherland Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 42. Rest of Europe Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 43. Rest of Europe Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 44. Rest of Europe Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 45. Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 46. Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 47. Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 48. Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By Country, 2019-2033
• Table 49. China Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 50. China Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 51. China Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 52. India Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 53. India Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 54. India Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 55. Japan Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 56. Japan Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 57. Japan Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 58. South Korea Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 59. South Korea Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 60. South Korea Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 61. Australia Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 62. Australia Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 63. Australia Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 64. New Zealand Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 65. New Zealand Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 66. New Zealand Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 67. Singapore Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 68. Singapore Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 69. Singapore Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 70. Thailand Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 71. Thailand Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 72. Thailand Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 73. Vietnam Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 74. Vietnam Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 75. Vietnam Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 76. Rest of Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 77. Rest of Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 78. Rest of Asia Pacific Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 79. Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 80. Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 81. Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 82. Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By Country, 2019-2033
• Table 83. Brazil Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 84. Brazil Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 85. Brazil Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 86. Mexico Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 87. Mexico Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 88. Mexico Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 89. Rest of Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 90. Rest of Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 91. Rest of Latin America Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 92. Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 93. Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 94. Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 95. Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Country, 2019-2033
• Table 96. South Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 97. South Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 98. South Africa Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 99. Saudi Arabia Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 100. Saudi Arabia Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 101. Saudi Arabia Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 102. UAE Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 103. UAE Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 104. UAE Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033
• Table 105. Rest of Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2019-2033
• Table 106. Rest of Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2019-2033
• Table 107. Rest of Middle East & Africa Infectious Disease Therapeutics Market Value (US$ Mn), By End-use, 2019-2033

List of Figures

• Figure 1. Global Infectious Disease Therapeutics Market Snapshot: Market Value (US$ Mn), 2019-2033
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Infectious Disease Therapeutics Market
• Figure 5. Global Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 6. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 7. Global Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 8. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 9. Global Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 10. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 11. Global Infectious Disease Therapeutics Market Analysis, By Region, 2019, 2023 and 2033
• Figure 12. Global Infectious Disease Therapeutics Market Attractiveness Analysis, By Region
• Figure 13. North America Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 14. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 15. North America Infectious Disease Therapeutics Market (US$ Mn), By HIV, 2019-2033
• Figure 16. North America Infectious Disease Therapeutics Market (US$ Mn), By Hepatitis, 2019-2033
• Figure 17. North America Infectious Disease Therapeutics Market (US$ Mn), By Influenza, 2019-2033
• Figure 18. North America Infectious Disease Therapeutics Market (US$ Mn), By TB, 2019-2033
• Figure 19. North America Infectious Disease Therapeutics Market (US$ Mn), By Malaria, 2019-2033
• Figure 20. North America Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 21. North America Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 22. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 23. North America Infectious Disease Therapeutics Market (US$ Mn), by Antibiotics, 2019-2033
• Figure 24. North America Infectious Disease Therapeutics Market (US$ Mn), by Antiviral Drugs, 2019-2033
• Figure 25. North America Infectious Disease Therapeutics Market (US$ Mn), by Antifungal Drugs, 2019-2033
• Figure 26. North America Infectious Disease Therapeutics Market (US$ Mn), by Antiparasitic Drugs, 2019-2033
• Figure 27. North America Infectious Disease Therapeutics Market (US$ Mn), by Others, 2019-2033
• Figure 28. North America Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 29. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 30. North America Infectious Disease Therapeutics Market (US$ Mn), By Hospitals, 2019-2033
• Figure 31. North America Infectious Disease Therapeutics Market (US$ Mn), By Clinics, 2019-2033
• Figure 32. North America Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 33. North America Infectious Disease Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
• Figure 34. North America Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
• Figure 35. Europe Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 36. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 37. Europe Infectious Disease Therapeutics Market (US$ Mn), By HIV, 2019-2033
• Figure 38. Europe Infectious Disease Therapeutics Market (US$ Mn), By Hepatitis, 2019-2033
• Figure 39. Europe Infectious Disease Therapeutics Market (US$ Mn), By Influenza, 2019-2033
• Figure 40. Europe Infectious Disease Therapeutics Market (US$ Mn), By TB, 2019-2033
• Figure 41. Europe Infectious Disease Therapeutics Market (US$ Mn), By Malaria, 2019-2033
• Figure 42. Europe Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 43. Europe Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 44. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 45. Europe Infectious Disease Therapeutics Market (US$ Mn), by Antibiotics, 2019-2033
• Figure 46. Europe Infectious Disease Therapeutics Market (US$ Mn), by Antiviral Drugs, 2019-2033
• Figure 47. Europe Infectious Disease Therapeutics Market (US$ Mn), by Antifungal Drugs, 2019-2033
• Figure 48. Europe Infectious Disease Therapeutics Market (US$ Mn), by Antiparasitic Drugs, 2019-2033
• Figure 49. Europe Infectious Disease Therapeutics Market (US$ Mn), by Others, 2019-2033
• Figure 50. Europe Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 51. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 52. Europe Infectious Disease Therapeutics Market (US$ Mn), By Hospitals, 2019-2033
• Figure 53. Europe Infectious Disease Therapeutics Market (US$ Mn), By Clinics, 2019-2033
• Figure 54. Europe Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 55. Europe Infectious Disease Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
• Figure 56. Europe Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
• Figure 57. Asia Pacific Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 58. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 59. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By HIV, 2019-2033
• Figure 60. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Hepatitis, 2019-2033
• Figure 61. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Influenza, 2019-2033
• Figure 62. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By TB, 2019-2033
• Figure 63. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Malaria, 2019-2033
• Figure 64. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 65. Asia Pacific Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 66. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 67. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), by Antibiotics, 2019-2033
• Figure 68. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), by Antiviral Drugs, 2019-2033
• Figure 69. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), by Antifungal Drugs, 2019-2033
• Figure 70. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), by Antiparasitic Drugs, 2019-2033
• Figure 71. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), by Others, 2019-2033
• Figure 72. Asia Pacific Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 73. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 74. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Hospitals, 2019-2033
• Figure 75. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Clinics, 2019-2033
• Figure 76. Asia Pacific Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 77. Asia Pacific Infectious Disease Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
• Figure 78. Asia Pacific Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
• Figure 79. Latin America Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 80. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 81. Latin America Infectious Disease Therapeutics Market (US$ Mn), By HIV, 2019-2033
• Figure 82. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Hepatitis, 2019-2033
• Figure 83. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Influenza, 2019-2033
• Figure 84. Latin America Infectious Disease Therapeutics Market (US$ Mn), By TB, 2019-2033
• Figure 85. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Malaria, 2019-2033
• Figure 86. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 87. Latin America Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 88. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 89. Latin America Infectious Disease Therapeutics Market (US$ Mn), by Antibiotics, 2019-2033
• Figure 90. Latin America Infectious Disease Therapeutics Market (US$ Mn), by Antiviral Drugs, 2019-2033
• Figure 91. Latin America Infectious Disease Therapeutics Market (US$ Mn), by Antifungal Drugs, 2019-2033
• Figure 92. Latin America Infectious Disease Therapeutics Market (US$ Mn), by Antiparasitic Drugs, 2019-2033
• Figure 93. Latin America Infectious Disease Therapeutics Market (US$ Mn), by Others, 2019-2033
• Figure 94. Latin America Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 95. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 96. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Hospitals, 2019-2033
• Figure 97. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Clinics, 2019-2033
• Figure 98. Latin America Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 99. Latin America Infectious Disease Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
• Figure 100. Latin America Infectious Disease Therapeutics Market Attractiveness Analysis, By Country
• Figure 101. Middle East & Africa Infectious Disease Therapeutics Market Analysis, By Disease Type, 2019, 2023 and 2033
• Figure 102. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Disease Type
• Figure 103. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By HIV, 2019-2033
• Figure 104. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Hepatitis, 2019-2033
• Figure 105. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Influenza, 2019-2033
• Figure 106. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By TB, 2019-2033
• Figure 107. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Malaria, 2019-2033
• Figure 108. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 109. Middle East & Africa Infectious Disease Therapeutics Market Analysis, By Treatment Type, 2019, 2023 and 2033
• Figure 110. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
• Figure 111. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), by Antibiotics, 2019-2033
• Figure 112. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), by Antiviral Drugs, 2019-2033
• Figure 113. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), by Antifungal Drugs, 2019-2033
• Figure 114. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), by Antiparasitic Drugs, 2019-2033
• Figure 115. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), by Others, 2019-2033
• Figure 116. Middle East & Africa Infectious Disease Therapeutics Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 117. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By End-use
• Figure 118. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Hospitals, 2019-2033
• Figure 119. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Clinics, 2019-2033
• Figure 120. Middle East & Africa Infectious Disease Therapeutics Market (US$ Mn), By Others, 2019-2033
• Figure 121. Middle East & Africa Infectious Disease Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
• Figure 122. Middle East & Africa Infectious Disease Therapeutics Market Attractiveness Analysis, By Country